Updated Date:
02 Oct 2026
Product Detail:
Pfizer (Australia) CYTARABINE 100mg/5mL injection vial
Shortage Status:
Anticipated
AUST R:
11351
Availability:
Available
Active Ingredient:
cytarabine
Reason:
Manufacturing
Dosage Form:
Injection,solution
Supply Impact Dates
From 18 Dec 2026
To 30 Jun 2028
Management Action:
The sponsor is closely controlling the supply. An overseas-registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: www.tga.gov.au/resources/section-19a-approvals